Evotec - Research never stops
  • Loading...

Archive



Dec 10, 2008

Jörn Aldag resigns as CEO of Evotec AG

- read more
Dec 03, 2008

Evotec Announces Three-Year Drug Discovery Collaboration

- read more
Nov 14, 2008

Evotec Reports Strong Third Quarter 2008 and Improves Full-Year Guidance

- read more
Oct 30, 2008

Evotec Earns Two Milestone Payments from Boehringer Ingelheim

- read more
Oct 27, 2008

Evotec Reports Phase I Safety Data from Tyramine Interaction Study with EVT 302

- read more
Oct 09, 2008

Evotec Announces Phase I Initiation with P2X7 Antagonist

- read more
Sep 16, 2008

Evotec Participates in the Sale of Direvo Biotech to Bayer Healthcare

- read more
Sep 11, 2008

Evotec Reports Start of Phase II Proof-of-Concept Quit Rate Study with EVT 302 and Results of Craving Study

- read more
Sep 02, 2008

Evotec and Boehringer Ingelheim Achieve Milestone in Joint Discovery Collaboration

- read more
Aug 06, 2008

Evotec Reports Results of the First Half of 2008

- read more
Aug 01, 2008

Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer Inc.

- read more
Jul 21, 2008

Dr Flemming Ornskov Nominated for Election as Chairman of the Supervisory Board of Evotec

- read more
Jul 03, 2008

Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study

- read more
May 08, 2008

Evotec Reports First Quarter 2008 Results

- read more
May 05, 2008

Evotec Completes Acquisition of Renovis

- read more
May 02, 2008

Evotec Completes Acquisition of Renovis

- read more
May 01, 2008

Renovis Stockholders Approve Acquisition by Evotec

- read more
Mar 28, 2008

Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity during the Performance of Cognitive Tasks

- read more
Mar 28, 2008

Evotec Announces Financial Results for 2007

- read more
Mar 27, 2008

Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec

- read more
Mar 26, 2008

Evotec's Registration Statement in Connection with its Proposed Acquisition of Renovis Declared Effective

- read more
Mar 12, 2008

Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery

- read more
Mar 06, 2008

Evotec Expands Collaboration with InterMune

- read more
Feb 28, 2008

Evotec Starts Phase II in Smoking Cessation with EVT 302

- read more
Feb 14, 2008

Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million

- read more
Jan 07, 2008

Phase I Safety and Tolerability Study with EVT 302 Successfully Completed

- read more
Jan 07, 2008

Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis

- read more